Analyst Articles

Many of you invest right alongside me and my $100,000 Real-Money Portfolio. And since your money is at stake here, along with the $100,000 in real money that StreetAuthority has given me to invest, I’m constantly monitoring my holdings. As some of you may have noticed, there’s… Read More

Investors focused on larger companies saw their ups and downs in 2011. Rather than focus on the usual suspects, perhaps they should have been focused on antimony. It’s an obscure — and toxic — element that has some appealing industrial applications such as flame retardants and in solder and ball… Read More

As an income investor, my favorite combination is a high-yielding stock poised for above-average dividend growth. Fortunately, these stocks aren’t that difficult to find if you know what to look for. I find the best dividend growth prospects are companies with… Read More

Unless you frequent our website, StreetAuthority.com, I’d guess you’ve never heard of David Sterman. That’s about to change… Dave has worked as an investment analyst for nearly two decades. He started his career in equity research at Smith Barney, culminating in a position as… Read More

The appeal of finding the right biotech stock is self-evident. If you get it right, and a cutting-edge biotech scores a major win with a breakthrough drug treatment, then you can score huge gains. Last month, I reviewed my performance over the course of 2011 in hopes… Read More

We humans are pretty predictable. We live our lives in certain patterns and according to certain preferences. There was a time when no one knew what those preferences were. The guy taking my order at a restaurant might remember I like Diet Coke, or the mechanic might… Read More